Anika Hoffmann

Craniopharyngioma

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis

RETRACTION Novel perspectives on hypothalamic-pituitary dysfunction as a risk factor for non-alcoholic fatty liver disease

Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007

Oxytocin in survivors of childhood-onset craniopharyngioma

First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma

Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes

Fusiform dilatation of the internal carotid artery in childhood-onset craniopharyngioma: multicenter study on incidence and long-term outcome

Diencephalic Syndrome in Childhood Craniopharyngioma—Results of German Multicenter Studies on 485 Long-term Survivors of Childhood Craniopharyngioma

Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma

Childhood Craniopharyngioma – Changes of Treatment Strategies in the Trials KRANIOPHARYNGEOM 2000/2007